STOCK TITAN

[8-K] Greenwich LifeSciences, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Global Mofy AI Limited (GMM) reports the full resolution of its April-2025 PIPE warrants. Purchasers first surrendered 25 % (≈2.55 m) of the 10.20 m warrants, leaving 7.65 m outstanding. Between 8-21 July 2025, those remaining warrants were fully exercised via the 0.8× cashless alternative, converting into 6,117,316 Class A ordinary shares. Because the exercise was cashless, the company received no incremental cash.

Following the issuance, share count stands at 25,495,761 Class A and 3,723,975 Class B shares. The new shares—about 24 % of the current Class A total—are registered under the effective Form F-1 (333-287230). This Form 6-K is also incorporated by reference into the company’s Form F-3 shelf (333-284554).

The update removes a sizeable derivative overhang, simplifying the capital structure, but simultaneously dilutes existing holders without providing fresh capital. No financial results, cash-flow data, or guidance were disclosed.

Global Mofy AI Limited (GMM) annuncia la completa risoluzione dei warrant PIPE di aprile 2025. Gli acquirenti hanno inizialmente restituito il 25% (circa 2,55 milioni) dei 10,20 milioni di warrant, lasciandone 7,65 milioni in sospeso. Tra l'8 e il 21 luglio 2025, i warrant rimanenti sono stati totalmente esercitati tramite l'alternativa cashless 0,8×, convertendosi in 6.117.316 azioni ordinarie di Classe A. Poiché l'esercizio è stato cashless, la società non ha ricevuto alcun incremento di liquidità.

Dopo l'emissione, il numero totale di azioni è di 25.495.761 di Classe A e 3.723.975 di Classe B. Le nuove azioni — circa il 24% del totale attuale di Classe A — sono registrate sotto l'efficace Modulo F-1 (333-287230). Questo Modulo 6-K è inoltre incorporato per riferimento nel Modulo F-3 shelf della società (333-284554).

L'aggiornamento elimina un considerevole onere derivato, semplificando la struttura del capitale, ma allo stesso tempo diluisce gli azionisti esistenti senza fornire nuovo capitale. Non sono stati divulgati risultati finanziari, dati sui flussi di cassa o indicazioni future.

Global Mofy AI Limited (GMM) informa la resolución completa de sus warrants PIPE de abril de 2025. Los compradores inicialmente devolvieron el 25% (≈2,55 millones) de los 10,20 millones de warrants, quedando 7,65 millones pendientes. Entre el 8 y el 21 de julio de 2025, esos warrants restantes fueron totalmente ejercidos mediante la alternativa cashless 0,8×, convirtiéndose en 6.117.316 acciones ordinarias Clase A. Debido a que el ejercicio fue sin efectivo, la compañía no recibió dinero adicional.

Tras la emisión, el conteo de acciones es de 25.495.761 Clase A y 3.723.975 Clase B. Las nuevas acciones — aproximadamente el 24% del total actual de Clase A — están registradas bajo el Formulario F-1 efectivo (333-287230). Este Formulario 6-K también se incorpora por referencia en el formulario F-3 shelf de la compañía (333-284554).

La actualización elimina una considerable carga derivada, simplificando la estructura de capital, pero al mismo tiempo diluye a los accionistas existentes sin aportar capital fresco. No se divulgaron resultados financieros, datos de flujo de caja ni pronósticos.

Global Mofy AI Limited(GMM)는 2025년 4월 PIPE 워런트의 완전 해소를 보고합니다. 구매자들은 먼저 10.20백만 워런트 중 25%(약 255만 개)를 반납하여 765만 개가 남았습니다. 2025년 7월 8일부터 21일 사이에 남은 워런트는 0.8배 현금 없는 대안으로 전액 행사되어 6,117,316개의 클래스 A 보통주로 전환되었습니다. 현금 없는 행사였기 때문에 회사는 추가 현금을 받지 못했습니다.

발행 후 총 주식 수는 클래스 A 25,495,761주클래스 B 3,723,975주입니다. 신규 주식은 현재 클래스 A 총수의 약 24%이며, 유효한 F-1 양식(333-287230)에 등록되어 있습니다. 이 6-K 양식은 회사의 F-3 선반 양식(333-284554)에 참조로 포함되어 있습니다.

이번 업데이트는 상당한 파생상품 부담을 제거하여 자본 구조를 단순화하지만, 동시에 기존 주주를 희석시키면서도 신자본을 제공하지는 않습니다. 재무 결과, 현금 흐름 데이터 또는 가이던스는 공개되지 않았습니다.

Global Mofy AI Limited (GMM) annonce la résolution complète de ses warrants PIPE d’avril 2025. Les acheteurs ont d’abord rendu 25 % (environ 2,55 millions) des 10,20 millions de warrants, laissant 7,65 millions en circulation. Entre le 8 et le 21 juillet 2025, ces warrants restants ont été exercés intégralement via l’option cashless à 0,8×, se convertissant en 6 117 316 actions ordinaires de Classe A. Comme l’exercice était cashless, la société n’a reçu aucune entrée de trésorerie supplémentaire.

Après émission, le nombre d’actions s’élève à 25 495 761 de Classe A et 3 723 975 de Classe B. Les nouvelles actions — environ 24 % du total actuel de Classe A — sont enregistrées sous le formulaire F-1 en vigueur (333-287230). Ce formulaire 6-K est également incorporé par référence dans le formulaire F-3 shelf de la société (333-284554).

Cette mise à jour supprime un important passif dérivé, simplifiant la structure du capital, mais dilue simultanément les actionnaires existants sans apporter de nouveau capital. Aucun résultat financier, données de flux de trésorerie ou prévisions n’ont été communiqués.

Global Mofy AI Limited (GMM) meldet die vollständige Abwicklung seiner PIPE-Warrants von April 2025. Die Käufer gaben zunächst 25 % (ca. 2,55 Mio.) der 10,20 Mio. Warrants zurück, sodass 7,65 Mio. ausstanden. Zwischen dem 8. und 21. Juli 2025 wurden die verbleibenden Warrants vollständig über die 0,8× cashless Alternative ausgeübt, was zur Umwandlung in 6.117.316 Stammaktien der Klasse A führte. Da die Ausübung cashless erfolgte, erhielt das Unternehmen keinen zusätzlichen Geldzufluss.

Nach der Ausgabe beträgt die Aktienanzahl 25.495.761 Klasse A und 3.723.975 Klasse B. Die neuen Aktien – etwa 24 % des aktuellen Klasse-A-Bestands – sind unter dem wirksamen Formular F-1 (333-287230) registriert. Dieses Formular 6-K ist ebenfalls durch Verweis in das F-3-Shelf-Formular des Unternehmens (333-284554) aufgenommen.

Das Update beseitigt eine erhebliche derivative Belastung und vereinfacht die Kapitalstruktur, verwässert jedoch gleichzeitig die bestehenden Aktionäre, ohne frisches Kapital bereitzustellen. Finanzielle Ergebnisse, Cashflow-Daten oder Prognosen wurden nicht veröffentlicht.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Large warrant block removed but 24 % dilution occurs with zero cash inflow—net negative for existing shareholders.

The voluntary surrender of 25 % of the warrants is constructive because it eliminates 2.55 m potential shares and reduces headline overhang risk. However, the cashless exercise of the remaining 7.65 m warrants expands the Class A float by 6.12 m shares—roughly one quarter of shares now outstanding—without adding capital that could fund growth. The transaction therefore pressures per-share metrics and may weigh on market price despite a cleaner cap table. No earnings data or strategic use of funds offset the dilution, and the company still has dual-class governance (3.72 m Class B shares) that concentrates voting power. Overall impact skews negative.

Global Mofy AI Limited (GMM) annuncia la completa risoluzione dei warrant PIPE di aprile 2025. Gli acquirenti hanno inizialmente restituito il 25% (circa 2,55 milioni) dei 10,20 milioni di warrant, lasciandone 7,65 milioni in sospeso. Tra l'8 e il 21 luglio 2025, i warrant rimanenti sono stati totalmente esercitati tramite l'alternativa cashless 0,8×, convertendosi in 6.117.316 azioni ordinarie di Classe A. Poiché l'esercizio è stato cashless, la società non ha ricevuto alcun incremento di liquidità.

Dopo l'emissione, il numero totale di azioni è di 25.495.761 di Classe A e 3.723.975 di Classe B. Le nuove azioni — circa il 24% del totale attuale di Classe A — sono registrate sotto l'efficace Modulo F-1 (333-287230). Questo Modulo 6-K è inoltre incorporato per riferimento nel Modulo F-3 shelf della società (333-284554).

L'aggiornamento elimina un considerevole onere derivato, semplificando la struttura del capitale, ma allo stesso tempo diluisce gli azionisti esistenti senza fornire nuovo capitale. Non sono stati divulgati risultati finanziari, dati sui flussi di cassa o indicazioni future.

Global Mofy AI Limited (GMM) informa la resolución completa de sus warrants PIPE de abril de 2025. Los compradores inicialmente devolvieron el 25% (≈2,55 millones) de los 10,20 millones de warrants, quedando 7,65 millones pendientes. Entre el 8 y el 21 de julio de 2025, esos warrants restantes fueron totalmente ejercidos mediante la alternativa cashless 0,8×, convirtiéndose en 6.117.316 acciones ordinarias Clase A. Debido a que el ejercicio fue sin efectivo, la compañía no recibió dinero adicional.

Tras la emisión, el conteo de acciones es de 25.495.761 Clase A y 3.723.975 Clase B. Las nuevas acciones — aproximadamente el 24% del total actual de Clase A — están registradas bajo el Formulario F-1 efectivo (333-287230). Este Formulario 6-K también se incorpora por referencia en el formulario F-3 shelf de la compañía (333-284554).

La actualización elimina una considerable carga derivada, simplificando la estructura de capital, pero al mismo tiempo diluye a los accionistas existentes sin aportar capital fresco. No se divulgaron resultados financieros, datos de flujo de caja ni pronósticos.

Global Mofy AI Limited(GMM)는 2025년 4월 PIPE 워런트의 완전 해소를 보고합니다. 구매자들은 먼저 10.20백만 워런트 중 25%(약 255만 개)를 반납하여 765만 개가 남았습니다. 2025년 7월 8일부터 21일 사이에 남은 워런트는 0.8배 현금 없는 대안으로 전액 행사되어 6,117,316개의 클래스 A 보통주로 전환되었습니다. 현금 없는 행사였기 때문에 회사는 추가 현금을 받지 못했습니다.

발행 후 총 주식 수는 클래스 A 25,495,761주클래스 B 3,723,975주입니다. 신규 주식은 현재 클래스 A 총수의 약 24%이며, 유효한 F-1 양식(333-287230)에 등록되어 있습니다. 이 6-K 양식은 회사의 F-3 선반 양식(333-284554)에 참조로 포함되어 있습니다.

이번 업데이트는 상당한 파생상품 부담을 제거하여 자본 구조를 단순화하지만, 동시에 기존 주주를 희석시키면서도 신자본을 제공하지는 않습니다. 재무 결과, 현금 흐름 데이터 또는 가이던스는 공개되지 않았습니다.

Global Mofy AI Limited (GMM) annonce la résolution complète de ses warrants PIPE d’avril 2025. Les acheteurs ont d’abord rendu 25 % (environ 2,55 millions) des 10,20 millions de warrants, laissant 7,65 millions en circulation. Entre le 8 et le 21 juillet 2025, ces warrants restants ont été exercés intégralement via l’option cashless à 0,8×, se convertissant en 6 117 316 actions ordinaires de Classe A. Comme l’exercice était cashless, la société n’a reçu aucune entrée de trésorerie supplémentaire.

Après émission, le nombre d’actions s’élève à 25 495 761 de Classe A et 3 723 975 de Classe B. Les nouvelles actions — environ 24 % du total actuel de Classe A — sont enregistrées sous le formulaire F-1 en vigueur (333-287230). Ce formulaire 6-K est également incorporé par référence dans le formulaire F-3 shelf de la société (333-284554).

Cette mise à jour supprime un important passif dérivé, simplifiant la structure du capital, mais dilue simultanément les actionnaires existants sans apporter de nouveau capital. Aucun résultat financier, données de flux de trésorerie ou prévisions n’ont été communiqués.

Global Mofy AI Limited (GMM) meldet die vollständige Abwicklung seiner PIPE-Warrants von April 2025. Die Käufer gaben zunächst 25 % (ca. 2,55 Mio.) der 10,20 Mio. Warrants zurück, sodass 7,65 Mio. ausstanden. Zwischen dem 8. und 21. Juli 2025 wurden die verbleibenden Warrants vollständig über die 0,8× cashless Alternative ausgeübt, was zur Umwandlung in 6.117.316 Stammaktien der Klasse A führte. Da die Ausübung cashless erfolgte, erhielt das Unternehmen keinen zusätzlichen Geldzufluss.

Nach der Ausgabe beträgt die Aktienanzahl 25.495.761 Klasse A und 3.723.975 Klasse B. Die neuen Aktien – etwa 24 % des aktuellen Klasse-A-Bestands – sind unter dem wirksamen Formular F-1 (333-287230) registriert. Dieses Formular 6-K ist ebenfalls durch Verweis in das F-3-Shelf-Formular des Unternehmens (333-284554) aufgenommen.

Das Update beseitigt eine erhebliche derivative Belastung und vereinfacht die Kapitalstruktur, verwässert jedoch gleichzeitig die bestehenden Aktionäre, ohne frisches Kapital bereitzustellen. Finanzielle Ergebnisse, Cashflow-Daten oder Prognosen wurden nicht veröffentlicht.

false 0001799788 0001799788 2025-07-19 2025-07-19 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) July 19, 2025

 

Greenwich LifeSciences, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   001-39555   20-5473709

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I. R. S. Employer

Identification No.)

 

3992 Bluebonnet Dr, Building 14

Stafford, TX 77477

(Address of principal executive offices, including ZIP code)

 

(832) 819-3232

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common stock, $0.001 par value   GLSI   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 4.01Changes in Registrant’s Certifying Accountant.

 

On July 19, 2025, the audit committee of the Board of Directors of Greenwich LifeSciences, Inc. (the “Company”) approved the dismissal of RBSM LLP (“RBSM”) as the Company’s independent registered public accounting firm and approved the engagement of MaloneBailey LLP (“MaloneBailey”) as the Company’s independent registered public accounting firm to audit the Company’s consolidated financial statements for the year ended December 31, 2025. Accordingly, on July 19, 2025, RBSM was informed that it would be dismissed as the Company’s independent registered public accounting firm, effective immediately.

 

The report of RBSM on the Company’s financial statements as of December 31, 2024 and 2023, and the related statements of operations, changes in stockholders’ equity and cash flows for the years ended December 31, 2024 and 2023 did not contain an adverse opinion or a disclaimer of opinion, nor was it qualified or modified as to uncertainty, audit scope or accounting principles.

 

During the fiscal years ended December 31, 2024 and 2023 there have been no “reportable events” (as defined in Item 304(a)(1)(v) of Regulation S-K), except for the material weaknesses in the Company’s internal control over financial reporting described in Part II, Item 9A, “Controls and Procedures,” in the Company’s annual reports on Form 10-K for the years ended December 31, 2024 and 2023, respectively and in Part I, Item 4, “Controls and Procedures,” in the Company’s quarterly reports on Form 10-Q for the quarters ended March 31, 2024, June 30, 2024, September 30, 2024 and March 31, 2025 filed with the SEC on May 20, 2024, August 14, 2024, November 14, 2024 and May 20, 2025, respectively. The Audit Committee has discussed the material weaknesses in the Company’s internal control over financial reporting with RBSM and has authorized RBSM to respond fully to the inquiries of MaloneBailey, the Company’s new independent registered public accountants, concerning such weakness.

 

During the years ended December 31, 2024 and 2023 and through July 19, 2025, there were no disagreements between the Company and RBSM on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of RBSM, would have caused it to make reference to the subject matter of the disagreement in connection with its report covering such period.

 

During the years ended December 31, 2024 and 2023 and through July 19, 2025, the date the audit committee of the Board approved the engagement of MaloneBailey as the Company’s independent registered public accounting firm, neither the Company nor anyone on the Company’s behalf consulted with MaloneBailey regarding (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s financial statements, and no written report or oral advice was provided to the Company by the Company that the Company concluded was an important factor considered by the Company in reaching a decision as to the accounting, auditing or financial reporting issue; or (ii) any matter that was either the subject of a disagreement, as that term is described in Item 304(a)(1)(iv) of Regulation S-K under the Exchange Act, or a reportable event, as that term is defined in Item 304(a)(1)(v) of Regulation S-K under the Exchange Act.

 

The Company provided RBSM with a copy of the foregoing disclosures prior to the filing of this Report and requested that RBSM furnish the Company with a letter addressed to the SEC stating whether it agrees with the statements made by the Company set forth above. A copy of RBSM’s letter, dated July 22, 2025, is attached as Exhibit 16.1 to this Report.

 

Item 9.01 Financial Statements and Exhibits

 

(d) Exhibits    
     
16.1   Letter from RBSM LLP to the Securities and Exchange Commission dated July 22, 2025.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

-2-

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Greenwich LifeSciences, Inc.
     
Date: July 24, 2025 By: /s/ Snehal Patel
    Snehal Patel
    Chief Executive Officer

 

-3-

Greenwich Lifesciences Inc

NASDAQ:GLSI

GLSI Rankings

GLSI Latest News

GLSI Stock Data

153.60M
6.11M
53.05%
9.1%
4.9%
Biotechnology
Pharmaceutical Preparations
Link
United States
STAFFORD